Mohammad Azam, PhD
Member, Division of Experimental Hematology & Cancer Biology
Mohammad Azam, PhD, is interested in understanding molecular basis of human cancers, especially hematopoietic malignancies. His research group focuses on understanding the mechanisms of tyrosine kinase regulation, oncogene addiction and the development of cancer stem cells.
513-803-1413
mohammad.azam@cchmc.org
Kevin E. Bove, MD
Staff Pathologist, Division of Pathology
Kevin E. Bove, MD, is currently focused on pathogenesis of biliary atresia and other cholestatic disorders of infancy, with long term research interests in the early stages of childhood neoplasia and childhood diseases of skeletal muscle and heart.
513-636-4261
kevin.bove@cchmc.org
Margaret H. Collins, MD
Staff Pathologist, Division of Pathology
Margaret H. Collins, MD, is a pediatric pathologist specializing in pediatric gastrointestinal pathology, especially eosinophilic gastrointestinal diseases. She has provided biopsy analyses, including primary study endpoints, for several clinical trials testing novel therapies to treat eosinophilic esophagitis in children. She also performs clinical research in other disorders of bowel immunity, and bowel motility disorders.
513-636-4261
margaret.collins@cchmc.org
Anita Gupta, MD
Staff Pathologist, Division of Pathology
Anita Gupta, MD, is a career academic pediatric pathologist at who functions as a surgical pathologist and electron microscopist. Current research focuses on liver tumors, cardiac transplants, vascular anomalies, and cilia abnormalities.
513-636-4261
anita.gupta@cchmc.org
Jennifer L. Kasten, MD, MSc(Oxon), MSc(London), FASCP
Staff Pathologist, Division of Pathology
Jennifer Kasten, MD, investigates the macroscopic and microscopic diseases of the heart in children. She is interested in bridging the divide between histologic diagnostic observations and patient/surgical outcomes. Cardiomyopathies and conduction system disorders are of particular interest. Separately, she studies global pathology and laboratory medicine capacity-building, and works to ensure all of the world's citizens have access to quality diagnostic pathology services.
513-636-9876
jennifer.kasten@cchmc.org
Daniel G. Leino, MD, MPH
Staff Pathologist, Division of Pathology
Daniel Leino, MD, investigates immune checkpoint regulation; solid organ, soft tissue, and bone tumor pathobiology; graft versus host disease and thrombotic microangiopathy; developmental biology of vasculature (zebrafish models) and intracerebral aneurysms; collagen mutation biology.
513-636-4261
daniel.leino@cchmc.org
Michael Losos, MD
Assistant Medical Director of Clinical Laboratories, Division of Pathology and Laboratory Medicine
Michael Losos, MD, conducts clinical research in coagulation and hemostasis as well as transfusion medicine with a particular interest in blood products and complications due to blood product storage.
513-803-8878
michael.losos@cchmc.org
Joel E. Mortensen, PhD
Director, Diagnostic Infectious Diseases Testing Laboratory (Microbiology and Virology)
Joel E. Mortensen, PhD, currently focuses is antimicrobial susceptibility testing of fastidious pediatric pathogens.
513-636-5310
joel.mortensen@cchmc.org
Jennifer L. Picarsic, MD
Co-Director, Langerhans Cell Histiocytosis Center
Jennifer Picarsic, MD's, research interests include pathology, classification, and molecular diagnostics of histiocytic neoplasms and disorders including Langerhans cell histiocytosis (LCH), Erdheim Chester disease (ECD), Rosai-Dorfman-Destombes disease (RDD), juvenile xanthogranuloma family (JXG), malignant histiocytic neoplasms, and hemophagocytic lymphohistiocytosis and macrophage activation syndrome (HLH/MAS).
513-636-4261
jennifer.picarsic@cchmc.org
Jerzy W. Stanek, MD, PhD
Staff Pathologist, Division of Pathology
Jerzy Stanek, MD, PhD, studied the placental features of in-utero hypoxia, perinatal infections, fetal vascular malperfusion, fetal congenital anomalies and maternal pregnancy complications.
513-636-8158
jerzy.stanek@cchmc.org
Keith F. Stringer, MD
Pathologist, Division of Pathology and Laboratory Medicine
Keith F. Stringer, MD, focuses on the application of the techniques of modern morphology in assessing diseased tissues. His work with these techniques, such as immunofluorescence microscopy and in situ hybridization, have contributed to dozens of publications elucidating features of the pathogenesis of allergic, neoplastic, developmental, and other disease processes.
513-636-4261
keith.stringer@cchmc.org
Peter H. Tang, PhD
Director, Special Chemistry
Peter H. Tang, PhD, focuses on the diagnosis of mitochondrial dysfunction, metabolic disorder, neurodegenerative disease, hemoglobin disorder, neurogenesis, and therapeutic drug monitoring. He has long term research interests in inventing novel approaches for clinical diagnosis by using HPLC and LC/MS.
513-636-3357
peter.tang@cchmc.org
Kathryn A. Wikenheiser-Brokamp, MD, PhD
Staff Pathologist, Division of Pathology
Kathryn A. Wikenheiser-Brokamp, MD, PhD, investigates lung development as well as pediatric and adult lung diseases. Her work focuses on elucidating molecular mechanisms controlling lung development and underlying disease pathogenesis with the ultimate goal of developing novel diagnostic, prognostic and targeted therapeutic strategies.
513-803-0239
kathryn.wikenheiser-brokamp@cchmc.org